The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Cancer‐associated fibroblast and M 2 macrophage markers together predict outcome in colorectal cancer patients
Open accessAbstract
Tumor epithelial cells within a tumor coexist with a complex microenvironment in which a variety of interactions between its various components determine the behavior of the primary tumors. Cancer‐associated fibroblasts (CAF) and M 2 macrophages, characterized by high expression of different markers, including α‐SMA, FSP 1 and FAP, or CD 163 and DCSIGN, respectively, are involved in the malignancy of different tumors. In the present study, expression of the above markers in CAF and M 2 macrophages was analyzed using RT‐PCR and immunohistochemistry in the normal mucosa and tumor tissue from a cohort of 289 colorectal cancer patients. Expression of CAF and M 2 markers is associated with the clinical outcome of colorectal cancer patients. Moreover, the combination of CAF and M 2 markers identifies three groups of patients with clear differences in the progression of the disease. This combined variable could be a decisive factor in the survival of advanced‐stage patients. Taken together, these analyses demonstrate the prognostic involvement of interrelationships between DCSIGN, CD 163, α‐SMA, FSP 1 and FAP markers in the survival of colon cancer patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mantovani, A., Allavena, P., Sica, A., & Balkwill, F. (2008) · Nature · doi:10.1038/nature07205 · Cited by 11,399
Exploring the full spectrum of macrophage activation
Mosser, D. M., & Edwards, J. P. (2008) · Nature Reviews Immunology · doi:10.1038/nri2448 · Cited by 9,144
Jemal, A., Siegel, R., Ward, E., Murray, T., Xu, J., Smigal, C., & Thun, M. J. (2006) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.56.2.106 · Cited by 5,314
Macrophage Diversity Enhances Tumor Progression and Metastasis
Qian, B.-Z., & Pollard, J. W. (2010) · Cell · doi:10.1016/j.cell.2010.03.014 · Cited by 5,188
Microenvironmental regulation of metastasis
Joyce, J. A., & Pollard, J. W. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2618 · Cited by 3,684
Tournigand, C., André, T., Achille, E., Lledo, G., Flesh, M., Mery-Mignard, D., Quinaux, E., Couteau, C., Buyse, M., Ganem, G., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.05.113 · Cited by 2,915
Bissell, M. J., & Radisky, D. (2001) · Nature Reviews Cancer · doi:10.1038/35094059 · Cited by 2,180
Stromal Fibroblasts in Cancer: A Novel Tumor-Promoting Cell Type
Orimo, A., & Weinberg, R. A. (2006) · Cell Cycle · doi:10.4161/cc.5.15.3112 · Cited by 799
Identification of fibroblast heterogeneity in the tumor microenvironment
Sugimoto, H., Mundel, T. M., Kieran, M. W., & Kalluri, R. (2006) · Cancer Biology & Therapy · doi:10.4161/cbt.5.12.3354 · Cited by 699
The Yin‐Yang of tumor‐associated macrophages in neoplastic progression and immune surveillance
Allavena, P., Sica, A., Garlanda, C., & Mantovani, A. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00607.x · Cited by 651
Tumor microenvironment: The role of the tumor stroma in cancer
Li, H., Fan, X., & Houghton, J. (2007) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21159 · Cited by 646
Activation of fibroblasts in cancer stroma
Räsänen, K., & Vaheri, A. (2010) · Experimental Cell Research · doi:10.1016/j.yexcr.2010.04.032 · Cited by 499
Know thy neighbor: stromal cells can contribute oncogenic signals
Tlsty, T. D., & Hein, P. W. (2001) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(00)00156-8 · Cited by 425
Clinical Implications of Fibroblast Activation Protein in Patients with Colon Cancer
Henry, L. R., Lee, H.-O., Lee, J. S., Klein-Szanto, A., Watts, P., Ross, E. A., Chen, W.-T., & Cheng, J. D. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1746 · Cited by 364
Stromal Myofibroblasts Predict Disease Recurrence for Colorectal Cancer
Tsujino, T., Seshimo, I., Yamamoto, H., Ngan, C. Y., Ezumi, K., Takemasa, I., Ikeda, M., Sekimoto, M., Matsuura, N., & Monden, M. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2191 · Cited by 352
Nakagawa, H., Liyanarachchi, S., Davuluri, R. V., Auer, H., Martin, E. W., de la Chapelle, A., & Frankel, W. L. (2004) · Oncogene · doi:10.1038/sj.onc.1208013 · Cited by 231
Stromagenesis: The changing face of fibroblastic microenvironments during tumor progression
Beacham, D. A., & Cukierman, E. (2005) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2005.05.003 · Cited by 225
High-Density Gene Expression Analysis of Tumor-Associated Macrophages from Mouse Mammary Tumors
Ojalvo, L. S., King, W., Cox, D., & Pollard, J. W. (2009) · The American Journal of Pathology · doi:10.2353/ajpath.2009.080676 · Cited by 221
Role of Cancer Microenvironment in Metastasis: Focus on Colon Cancer
Gout, S., & Huot, J. (2008) · Cancer Microenvironment · doi:10.1007/s12307-008-0007-2 · Cited by 187
Saadi, A., Shannon, N. B., Lao-Sirieix, P., O’Donovan, M., Walker, E., Clemons, N. J., Hardwick, J. S., Zhang, C., Das, M., Save, V., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0909797107 · Cited by 161
Domínguez‐Soto, Á., Sierra‐Filardi, E., Puig‐Kröger, A., Pérez-Maceda, B. T., Gómez, F., Corcuera, M. T., Sánchez‐Mateos, P., & Corbí, A. L. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1000475 · Cited by 154
Origin and function of tumor stroma fibroblasts
Xouri, G., & Christian, S. (2009) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2009.11.017 · Cited by 137
Nakayama, Y., Nagashima, N., Minagawa, N., Inoue, Y., Katsuki, T., Onitsuka, K., 佐古, 達., Hirata, K., Nagata, N., & Itoh, H. (2002) · PubMed · Cited by 76
SNAI1 expression in colon cancer related with CDH1 and VDR downregulation in normal adjacent tissue
Peña, C., García, J. M., Larriba, M. J., Barderas, R., Gómez, I., Herrera, M., García‐Barberán, V., Silva, J., Domínguez, G., Rodríguez, R., et al. (2009) · Oncogene · doi:10.1038/onc.2009.285 · Cited by 70
Self-citationTWIST1 Is Expressed in Colorectal Carcinomas and Predicts Patient Survival
Gómez, I., Peña, C., Herrera, M., Muñoz, C., Larriba, M. J., García‐Barberán, V., Domínguez, G., Silva, J., Rodríguez, R., de Herreros, A. G., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018023 · Cited by 68
Self-citationExpression of protein S100A4 is a predictor of recurrence in colorectal cancer
Kwak, J. (2010) · World Journal of Gastroenterology · doi:10.3748/wjg.v16.i31.3897 · Cited by 41
A Digest on the Role of the Tumor Microenvironment in Gastrointestinal Cancers
Augsten, M., Hägglöf, C., Peña, C., & Östman, A. (2010) · Cancer Microenvironment · doi:10.1007/s12307-010-0040-9 · Cited by 38
Self-citation
Cited by
Mao, X., Xu, J., Wang, W., Liang, C., Hua, J., Liu, J., Zhang, B., Meng, Q., Yu, X., & Shi, S. (2021) · Molecular Cancer · doi:10.1186/s12943-021-01428-1 · Cited by 2,290
Łukasiewicz, S., Czeczelewski, M., Forma, A., Baj, J., Sitarz, R., & Stanisławek, A. (2021) · Cancers · doi:10.3390/cancers13174287 · Cited by 1,960
Qi, J., Sun, H., Zhang, Y., Wang, Z., Xun, Z., Li, Z., Ding, X., Bao, R., Hong, L., Jia, W., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-29366-6 · Cited by 952
Cancer-associated fibroblasts: an emerging target of anti-cancer immunotherapy
Liu, T., Han, C., Wang, S., Fang, P., Ma, Z., Xu, L., & Yin, R. (2019) · Journal of Hematology & Oncology · doi:10.1186/s13045-019-0770-1 · Cited by 860
Wei, C., Yang, C., Wang, S., Shi, D., Zhang, C., Lin, X., Liu, Q., Dou, R., & Xiong, B. (2019) · Molecular Cancer · doi:10.1186/s12943-019-0976-4 · Cited by 833
Metadata
- Authors
- Herrera, M., Herrera, A., Domínguez, G., Silva, J., García, V., García, J. M., Gómez, I., Soldevilla, B., Muñoz, C., Provencio, M., Campos‐Martin, Y., García de Herreros, A., Casal, I., Bonilla, F., & Peña, C.
- Venue
- Cancer Science
- Publisher
- Wiley
- Published
- 2013-02-21
- Volume
- 104
- Issue
- 4
- Pages
- 437-444
- ISSN
- 1347-9032 (ISSN-L)
- 1349-7006
- OpenAlex
- W2061581062
- Cited by
- 289
- References
- 27
- FWCI
- 7.87
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.